Cannabidiol, or CBD for short, is a phyto-cannabinoid found in cannabis plants. However, it does not cause the same psychoactive effects as other naturally occurring cannabinoids (such as tetrahydrocannabinol, or THC). CBD induces feelings of sleepiness and tranquility, making it suitable for insomnia and other sleep disorders; CBD can be used to alleviate symptoms of epilepsy, diabetes, and anxiety disorders, as well. Legality is an issue for some; all 50 states have laws governing the sale, possession, and use of CBD, and they vary significantly (see the table below for a full analysis).
We don’t know how CBD affects the brain in any kind of depth. We don’t know which doses and delivery methods are best for different outcomes. We don’t know how CBD interacts with most other drugs or foods. We don’t know the differences between the effects of isolates and full-spectrum preparations. We don’t even know how many cannabinoids there are. California, for what it’s worth, seems aware and concerned about this whole thing.
In the European Union (EU), the cultivation of certain cannabis varieties is granted provided they are registered in the EU’s Common Catalogue of Varieties of Agricultural Plant Species  and the THC content does not exceed 0.2% of the dried flowers of the plant . In Canada, hemp is allowed to contain 0.3% THC , while Switzerland allows up to 1% THC . In most countries, viable seeds for planting may be purchased from certified seed companies only, in order to make sure that the correct hemp variety is indeed being cultivated. Additionally, hemp may typically only be grown in agricultural fields outdoors, while indoor cultivation is usually forbidden. In some countries (e.g., The Netherlands), growing hemp is allowed only with the intent to produce fibers or seeds. As a result, the act of harvesting fiber cannabis for its CBD is a violation of narcotics laws . New cannabis varieties (for example developed to yield a higher content of CBD) are not (yet) registered as approved hemp varieties, and therefore cannot be freely cultivated, while the official registration process takes several years to complete.
Sativex, an oral spray containing both CBD and THC, can treat MS-induced pain. During one study, researchers gave Sativex to 47 participants with MS. Results were largely positive. Patients who used this spray felt notably better. Their muscle and walking spasms decreased, and they felt pain relief. Thanks to studies such as this one, several countries approved using Sativex in MS treatment.
Kat’s Naturals offers five non-THC tinctures of varying concentrations: Heal and Naked (1,500mg), Balance (750mg), Metabolize (500mg), and Relax (300mg). All five tinctures are available in 5mL to 30mL containers, which can sustain users anywhere from five days to four weeks, depending on their dosage. Kat’s Naturals tinctures are derived from 99% pure fat soluble CBD isolate and pose no risk for yielding positive results on drug tests. For best results, Kat’s Naturals recommends ingesting three to five drops under the tongue and holding them in place for 60 seconds.
CBD, known scientifically as cannabidiol, is the second most commonly occurring cannabinoid within the marijuana plant, ranking in just below THC, or tetrahydrocannabinol. What is unique and distinctive about CBD, unlike THC this component produces zero psychoactive effects, meaning that it does not create the typical high and euphoria that is linked with marijuana. Furthermore, it has proved to generate immense healing and a multitude of medically beneficial abilities. CBD helps pain on an anatomical level by directly targeting the body’s endocannabinoid system (ECS), which naturally produces some cannabinoids on its own, known as endocannabinoids.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.